Cell therapy weekly: Positive results from regenerative tissue clinical trial for deep, partial-thickness thermal burns
This week: FDA has placed regulatory brakes on an autologous, gene-corrected cell therapy for epidermolysis bullosa and six new UK modules for cell therapy manufacturing have been completed.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>